• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国卫生研究院文献>other >Association of Host Pharmacodynamic Effects with Virologic Response to Peginterferon Alfa-2a/Ribavirin in Chronic Hepatitis C
【2h】

Association of Host Pharmacodynamic Effects with Virologic Response to Peginterferon Alfa-2a/Ribavirin in Chronic Hepatitis C

机译：宿主药物动力学作用与病毒反应对慢性丙型肝炎的PEGINTERFEREN ALFA-2A /利巴韦林的关联

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Patients receiving therapy for chronic hepatitis C virus (HCV) infection frequently experience cytopenias and weight loss. We retrospectively assessed the pharmacodynamic effects of peginterferon alfa-2a and ribavirin by evaluating the relationship between changes in hematologic parameters, body weight, and virologic response. Patients with HCV genotypes 1, 4, 5, or 6 receiving 24 or 48 weeks of peginterferon alfa-2a and ribavirin therapy were pooled from four phase III/IV trials. Maximum decreases in hemoglobin, neutrophils, platelets, and weight during therapy were assessed by virologic response category (sustained virologic response [SVR], relapse, breakthrough, and nonresponder) and by race/ethnicity. Of 1778 patients analyzed, more than half were male, non-Hispanic Caucasians, infected with HCV genotype 1, with baseline HCV RNA >800,000, and alanine aminotransferase ≤3 × ULN. Virologic responders (SVR, relapse, and breakthrough) experienced greater maximum decreases from baseline in neutrophils, platelets, hemoglobin, and weight compared with nonresponders; however, no clear trend was observed between SVR, relapse, and breakthrough. After adjusting for drug exposure and treatment duration, only decreases in neutrophils remained associated with virologic response. Significantly greater declines in neutrophils (P<0.0001) and platelets (P<0.005) were observed at weeks 4, 12, and 24 of therapy in virologic responders compared with nonresponders. This difference between responders and nonresponders was also observed among race/ethnic groups although statistical significance was not consistent across all groups.ConclusionThis post hoc analysis of HCV patients treated with peginterferon alfa-2a and ribavirin shows that maximum decreases from baseline in hematologic parameters and weight loss were associated with virologic response. However, after adjusting for drug exposure and accounting for duration of therapy, only neutropenia was independently associated with virologic response.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号